Luciana Petti

Luciana Petti

Auto-generated profile, based on publicly available information

Luciana Petti

Université Côte d’Azur, CNRS UMR7275, INSERM U1323, Institut de Pharmacologie Moléculaire et Cellulaire, Valbonne, France

Research Focus & Metrics

Academic Career Length

14Years (2013-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 November 2017 in Gastroenterology
Verified
Journal Article
Closed access
FUFederica Ungaro
Federica Ungaro
CTCarlotta Tacconi
Carlotta Tacconi
LMLuca Massimino
Luca Massimino
PCPaola Antonia Corsetto
Paola Antonia Corsetto
CCCarmen Correale
Carmen Correale
SDSilvio Danese
Silvio Danese

1 March 2013 in Inflammatory Bowel Diseases
Verified
Journal Article
Open access
FCFlavio Andrea Caprioli
Flavio Andrea Caprioli
FBFrancesca Bosè
Francesca Bosè
Riccardo Lorenzo RossiRiccardo Lorenzo Rossi
Riccardo Lorenzo Rossi
LPLuciana Petti
Luciana Petti
CVChiara Vigano'
Chiara Vigano'
Eva RealiEva Reali
Eva Reali
Antibodies against tumor necrosis factor represent an effective therapy for patients with inflammatory bowel disease. Despite their successful results, the exact mechanism by which infliximab suppresses intestinal inflammation is still a matter of debate. In this study, we used a translational approach to identify the key mechanisms associated with resolution of mucosal inflammation induced by infliximab. A total of 16 patients with active inflammatory bowel disease (9 with Crohn's disease and 7 with ulcerative colitis) and 16 controls were enrolled in the study. Patients received infliximab infusions at 0, 2, and 6 weeks. At enrollment and at week 6, patients underwent flexible sigmoidoscopy, and biopsies were taken from the sigmoid colon. RNA was extracted, and mucosal expression of 96 immune-related genes was evaluated by qRT-PCR and confirmed by immunofluorescence microscopy on tissue. Correlation between infliximab-induced gene expression modulation and endoscopic response to therapy was calculated. Lamina propria mononuclear cell apoptosis induced by infliximab was evaluated on tissue sections by the terminal deoxynucleotidyl transferase dUTP nick end labeling assay. We found that infliximab-induced downregulation of macrophage and Th17 pathway genes was significantly associated with both endoscopic response to the therapy and achievement of mucosal healing. Importantly, the observed reduction of lamina propria CD68 macrophages was associated with an increased rate of macrophage apoptosis. The 2 mechanisms associated with infliximab-induced resolution of intestinal inflammation are the reduction of lamina propria infiltrating CD68 macrophages and the downregulation of interleukin 17A. Moreover, the data suggest that infliximab-induced macrophage apoptosis may represent a key mechanism for the therapeutic success of anti-tumor necrosis factor antibodies.

26 September 2025 in Cancer Immunology Research
Verified
Journal Article
Closed access
RERoxane ELALDI
Roxane ELALDI
AMAïda Meghraoui-Kheddar
Aïda Meghraoui-Kheddar
AEAxel Elaldi
Axel Elaldi
LPLuciana Petti
Luciana Petti
AGAlizé Gouleau
Alizé Gouleau
FAFabienne Anjuère
Fabienne Anjuère
Current histopathologic classifications do not reliably distinguish patients with primary cutaneous squamous cell carcinomas (cSCC) at risk of relapse from those with nonrelapsing tumors. This underscores the need for molecular signatures capable of stratifying patients during primary tumor resection. In this study, we used high-dimensional imaging mass cytometry and a 39-antibody panel to define the immune landscape of 20 primary cSCC with distinct clinical outcomes, four relapsing cSCC, and their perilesional skins. Computational analysis of spatially resolved single-cell data from 47 imaging mass cytometry images identified 12 immune-cell subsets that discriminated primary cSCC from perilesional skin. Regulatory T cells, cytotoxic CD8+ T lymphocytes, and tumor-associated macrophages and neutrophils characterized tumors, whereas Langerhans cells and skin-resident macrophages defined perilesional skin. Skin-resident macrophages were characterized by the expression of CD206, CD11c, and HLA-DR and the absence of CD14. These cells infiltrated tumors from nonrelapsing patients more efficiently. We found a higher density of proliferating, mature, and cytotoxic cells within this macrophage subset, consistent with the absence of relapse. Spectral flow cytometry analysis on fresh tumor biopsies revealed that the skin-resident macrophages had phagocytic properties, suggesting a role in tumor antigen processing. Additionally, neighborhood profiling revealed that DC-LAMP+ dendritic cells were in close proximity with helper and cytotoxic T lymphocytes in primary cSCC from patients without relapse, indicative of active adaptive immunity. Our findings identify phagocytic skin-resident macrophages and dendritic cell–T cell clusters as features differentiating nonrelapsing cSCC from primary cSCC at risk of relapse. These data have the potential to guide the identification of prognostic biomarkers for cSCC.

2 December 2025
Verified
Other
Open access
RERoxane ELALDI
Roxane ELALDI
AMAïda Meghraoui-Kheddar
Aïda Meghraoui-Kheddar
AEAxel Elaldi
Axel Elaldi
LPLuciana Petti
Luciana Petti
AGAlizé Gouleau
Alizé Gouleau
FAFabienne Anjuère
Fabienne Anjuère
Supplementary Figure 8. Cell densities in cSCC from primary cSCC and relapsing cSCC from paired patients.

2 December 2025
Verified
Other
Open access
RERoxane ELALDI
Roxane ELALDI
AMAïda Meghraoui-Kheddar
Aïda Meghraoui-Kheddar
AEAxel Elaldi
Axel Elaldi
LPLuciana Petti
Luciana Petti
AGAlizé Gouleau
Alizé Gouleau
FAFabienne Anjuère
Fabienne Anjuère
Supplementary Figure 6. Cell densities in cSCC from different clinical situations.

2 December 2025
Verified
Other
Open access
RERoxane ELALDI
Roxane ELALDI
AMAïda Meghraoui-Kheddar
Aïda Meghraoui-Kheddar
AEAxel Elaldi
Axel Elaldi
LPLuciana Petti
Luciana Petti
AGAlizé Gouleau
Alizé Gouleau
FAFabienne Anjuère
Fabienne Anjuère
Supplementary Figure 2. Phenotypes of T cell subsets and Mono/Mac/DC subsets in perilesional NT skin and cSCC.